ATE428418T1 - Mit einem serotonin-transporter zusammenwirkende mittel zur krebsbehandlung - Google Patents

Mit einem serotonin-transporter zusammenwirkende mittel zur krebsbehandlung

Info

Publication number
ATE428418T1
ATE428418T1 AT03734774T AT03734774T ATE428418T1 AT E428418 T1 ATE428418 T1 AT E428418T1 AT 03734774 T AT03734774 T AT 03734774T AT 03734774 T AT03734774 T AT 03734774T AT E428418 T1 ATE428418 T1 AT E428418T1
Authority
AT
Austria
Prior art keywords
cell
serotonin transporter
cancer treatment
agents cooperate
sert
Prior art date
Application number
AT03734774T
Other languages
English (en)
Inventor
John Gordon
Nicholas Barnes
Original Assignee
Celentyx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celentyx Ltd filed Critical Celentyx Ltd
Application granted granted Critical
Publication of ATE428418T1 publication Critical patent/ATE428418T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03734774T 2002-02-01 2003-02-03 Mit einem serotonin-transporter zusammenwirkende mittel zur krebsbehandlung ATE428418T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0202337.2A GB0202337D0 (en) 2002-02-01 2002-02-01 Cancer treatment
PCT/GB2003/000436 WO2003063866A1 (en) 2002-02-01 2003-02-03 Agents which interact with a serotonin transporter for the treatment of cancer

Publications (1)

Publication Number Publication Date
ATE428418T1 true ATE428418T1 (de) 2009-05-15

Family

ID=9930195

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03734774T ATE428418T1 (de) 2002-02-01 2003-02-03 Mit einem serotonin-transporter zusammenwirkende mittel zur krebsbehandlung

Country Status (8)

Country Link
US (1) US20050182002A1 (de)
EP (1) EP1478360B1 (de)
AT (1) ATE428418T1 (de)
DE (1) DE60327173D1 (de)
DK (1) DK1478360T3 (de)
ES (1) ES2323953T3 (de)
GB (1) GB0202337D0 (de)
WO (1) WO2003063866A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1797427A4 (de) * 2004-09-22 2009-04-08 Odyssey Thera Inc Verfahren zur identifizierung neuer arzneimittel-leads und neuer therapeutischer verwendungen für bekannte arzneimittel
US8835506B2 (en) 2008-06-05 2014-09-16 Stc.Unm Methods and related compositions for the treatment of cancer
TWI546537B (zh) * 2009-05-19 2016-08-21 維維亞生技公司 提供針對血液腫瘤之體外個人化藥物測試之方法
JP5922563B2 (ja) * 2012-11-30 2016-05-24 国立大学法人 岡山大学 抗がん剤
EP2959904A1 (de) * 2014-06-27 2015-12-30 Institut De Recerca Contra La Leucemia Josep Carreras Verfahren zur Behandlung, Diagnose und Prognose einer hämatologischen Malignität
US20170304286A1 (en) * 2014-10-24 2017-10-26 Launx Biomedical Co., Ltd. New indication of paroxetine pharmaceutical composition for treating cancer
KR102123021B1 (ko) * 2018-07-26 2020-06-16 재단법인 대구경북과학기술원 세로토닌 재흡수 억제제 계열 항우울제에 대한 반응성 조절용 펩티드 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022085A1 (en) * 1995-01-17 1996-07-25 Pfizer Inc. The use of sertraline to treat cancer patients
US5955508A (en) * 1996-10-15 1999-09-21 Loyola University Of Chicago Method for the enhancement of lymphocyte activity against opportunistic microbial pathogens
US6162417A (en) * 1997-05-07 2000-12-19 Emory University Pyrrolo isoquinolines

Also Published As

Publication number Publication date
WO2003063866A1 (en) 2003-08-07
EP1478360B1 (de) 2009-04-15
EP1478360A1 (de) 2004-11-24
US20050182002A1 (en) 2005-08-18
ES2323953T3 (es) 2009-07-28
DK1478360T3 (da) 2009-07-13
GB0202337D0 (en) 2002-03-20
DE60327173D1 (de) 2009-05-28

Similar Documents

Publication Publication Date Title
BRPI0409523A (pt) método para o tratamento da dor neuropática, método de identificação de um composto e composição farmacêutica
ATE450269T1 (de) Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
TW200510375A (en) New compounds
FR2869231B1 (fr) Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine
EP1140840A4 (de) -g(v)-carboxyaryl substituierte diphenyl harnstoffe als raf kinase inhibitoren
MXPA05006359A (es) Tratamiento de la enfermedad a traves de inhibidores peptidos antimicrobianos.
EA200401365A1 (ru) Способы лечения илеуса
EP1505990A4 (de) Verfahren zur behandlung von hepatitis
GB0222514D0 (en) Organic compounds
MXPA05004697A (es) Soluciones farmaceuticas que comprenden un compuesto modafinil y uso para la fabricacion de un medicamento para tratar diferentes enfermedades.
CY1108599T1 (el) Η απλιδινη στην αντιμετωπιση του πολλαπλου μυελωματος
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
DE60108489D1 (de) Kombinationstherapien mit gefässschädigender aktivität
ATE428418T1 (de) Mit einem serotonin-transporter zusammenwirkende mittel zur krebsbehandlung
EE200200087A (et) Kompositsioon hepatotsellulaarse kartsinoomi raviks
ATE414100T1 (de) Zielgerichtete ligande gegen peyer&#39;s flecke- und/oder m-zellen
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
DE60236927D1 (de) Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba
ATE268170T1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
NO20051261L (no) Morfin-6-glukuronidsalt
DE60029762D1 (de) Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie
BR0112123A (pt) Composto
DE602006020838D1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
FI20030379A0 (fi) Uusi farmaseuttinen koostumus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties